Praxis Medica
Sign in
Issue image

More articles from Volume 44, Issue 1, 2015

HLORINIŠUĆA AKTIVNOST SERUMSKE MIJELOPEROKSIDAZE U AKUTNOM ISHEMIČNOM MOŽDANOM UDARU

KVANTITATIVNA ANALIZA MAKROFAGA U GINGIVITISU I PARODONTOPATIJI

Is hypertension, in children who are on chronic hemodialysis therapy, crucial for the development of cardiac hypertrophy?

LEČENJE INFERTILNIH I SUBFERTILNIH MUŠKARACA SA VARIKOKELOM MINIMALNO INVAZIVNIM HIRURŠKIM METODOM

HISTOLOŠKO-CITOLOŠKA KORELACIJA NALAZA I POUZDANOST PAPANICOLAU TESTA U OTKRIVANJU PREMALIGNIH I MALIGNIH PROMENA NA GRLIĆU MATERICE

EFIKASNOST I SIGURNOST TERAPIJE HRONIČNOG B VIRUSNOG HEPATITISA TENOFOVIROM KOD PACIJENATA SA REZISTENCIJOM NA LAMIVUDIN

N. Katanic ,
N. Katanic
View authors publications

Search this author on:

PubMed | Google Scholar
K. Bojovic ,
K. Bojovic
View authors publications

Search this author on:

PubMed | Google Scholar
D. Delic ,
D. Delic
View authors publications

Search this author on:

PubMed | Google Scholar
J. Simonovic ,
J. Simonovic
View authors publications

Search this author on:

PubMed | Google Scholar
J. Malinic ,
J. Malinic
View authors publications

Search this author on:

PubMed | Google Scholar
I. Milosevic
I. Milosevic
View authors publications

Search this author on:

PubMed | Google Scholar

Published: 01.12.2014.

Volume 44, Issue 1 (2015)

pp. 61-65;

https://doi.org/10.5937/pramed1501061k

Abstract

Keywords

chronic viral hepatitis B,

Lamivudine,

Tenofovir

References

1.
European Association for the Study of the Liver. EASL clinical practice guidelines: menagment of chronic hepatitis B. J Hepatol. 2009;227–42.
2.
Lokas, Mcmahon. Chronic hepatitis B. Hepatology. 2007;507–39.
3.
European Association for the Study of the Liver. EASL clinical practice guidelines: menagment of chronic hepatitis B. J Hepatol. 2012;167–85.
4.
Kao J. HBeAg positive chronic hepatitis B: why do I treat my patients with pegylated interferon? Liver International. 2014;112–8.
5.
Liaw Y, Sung J, Chow W. Lamivudine for patients with chronic hepatitis B and advanced liver disese. N Engl J Med. 2004;1521–31.
6.
Tenny D. J Hepatol. 2009;227–42.
7.
Cho I Lee. Efficacy and Safety of Tenofovir-Based Rescue Therapy for Chronic Hepatitis B Patients with Previous Nucleo(s/t)ide Treatment Failure. Gut and Liver. (1):64–9.
8.
Pol S, Lampertico P. First-line treatment of chronic hepatitis B with entecavir or tenofovir in “real-life” settings: from clinical trials to clinical practice. Journal of Viral hepatitis. 2012;377–86.
9.
Calvin QP. 2014;89789.
10.
Baran B. Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nuceloside/Nucleotide Analogue-Naïve Patients with Chronic Hepatitis B. Antimicrobial Agents and Chemotherapy. (4):1790–6.
11.
Gordon C. Efficacy of Tenofovir Disoprtoxil Fumarate at 240 Weeks in Patients With Chronic Hepatitis B With High Baseline Viral Load. Hepatology. 2013;(2):505–13.
12.
Pancq. Response to tenofovir monotherapy in chronic hepatitis B patients with prior suboptimal response to entecavir. J Viral hepatol. 2012;213–9.
13.
Marcellin P. Regression of cirhosis during treatment with tenofovir for chronic B hepatitis; a 5 yers open label follow up study. Lancet. 2013;468–75.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by
DOAJ
Google Scholar
ERIHPLUS
MIAR I
Crossref